Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/19/2003US20030113281 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
06/19/2003US20030113278 Treatment of excessive radiation (e.g. sunburn) exposure
06/19/2003US20030113276 Flexible polybutene strips for preventing gingivitis/whitening of teeth
06/19/2003US20030113269 Medical combinations comprising tiotropium and fluticasone proprionate
06/19/2003US20030113268 Degradation-resistant glucocorticosteroid formulations
06/19/2003US20030113263 Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
06/19/2003US20030111087 Process for the isolation of a major harmful oxidant from cigarette smoke
06/19/2003CA2822045A1 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003CA2655959A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
06/19/2003CA2484528A1 Isoflavone composition for oral delivery
06/19/2003CA2471743A1 Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds
06/19/2003CA2471742A1 Method of producing a nicotine composition
06/19/2003CA2470114A1 Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-heptanoic acid calcium salt (2:1)
06/19/2003CA2470104A1 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469730A1 Novel methods for treatment of cardiac arrhythmia, synthesis, and methods of use
06/19/2003CA2469709A1 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003CA2469670A1 Quinazoline derivatives for the treatment of abnormal cell growth
06/19/2003CA2469656A1 Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
06/19/2003CA2469622A1 Substituted hydroxyethylamines
06/19/2003CA2469616A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
06/19/2003CA2469615A1 Combination cancer therapy
06/19/2003CA2469613A1 Process for affecting neurologic progression
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2469596A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003CA2469595A1 Treatment of glioblastoma with thymosin-alpha 1
06/19/2003CA2469588A1 Highly concentrated stable meloxicam solutions for needleless injection
06/19/2003CA2469519A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds
06/19/2003CA2469494A1 Novel chimeric tnf ligands
06/19/2003CA2469387A1 In situ bonds
06/19/2003CA2469354A1 Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
06/19/2003CA2469340A1 Treating muscle wasting with selective androgen receptor modulators
06/19/2003CA2469336A1 Guanidinium transport reagents and conjugates
06/19/2003CA2469316A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003CA2469306A1 Methods and compositions for control of bone formation via modulation of sympathetic tone
06/19/2003CA2469304A1 6-o acyl ketolide antibacterials
06/19/2003CA2469204A1 Prospective identification and characterization of breast cancer stem cells
06/19/2003CA2469147A1 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
06/19/2003CA2469143A1 The use of acyl salicylates as heat shock inducers
06/19/2003CA2469021A1 Process for the synthesis of chirally pure .beta.-amino-alcohols
06/19/2003CA2469000A1 Method for reducing acne or improving skin tone
06/19/2003CA2468994A1 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
06/19/2003CA2468989A1 Treatment for age-related macular degeneration
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468794A1 Treatment of neoplasia
06/19/2003CA2468792A1 Glucosamine organic acid adducts
06/19/2003CA2468785A1 Beverage treated with nicotine
06/19/2003CA2468749A1 Use of an h1 antagonist and a safe steroid to treat rhinitis
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468266A1 Substituted bicyclic pyrimidinones as a mitotic kinesin ksp inhibitors
06/19/2003CA2468202A1 Assays and implements for determining and modulating hsp90 binding activity
06/19/2003CA2468190A1 New generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467916A1 Mitotic kinesin inhibitors
06/19/2003CA2467802A1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
06/19/2003CA2467726A1 Mitotic kinesin inhibitors
06/19/2003CA2467722A1 Thienopyrimidinone derivatives as mitotic kinesin inhibitors
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467614A1 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
06/19/2003CA2467593A1 Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2467245A1 Prevention of flap necrosis in plastic surgery
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/19/2003CA2465120A1 Composition and method for treating chronic allograft rejection
06/19/2003CA2464341A1 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
06/18/2003EP1319666A1 Novel antibacterial compounds
06/18/2003EP1319658A1 Imidazole derivatives or their salts
06/18/2003EP1319651A2 2-Aminopropane-1,3-diol compound, pharmaceutical use thereof and synthetic intermediates therefor
06/18/2003EP1319409A1 Solid preparations
06/18/2003EP1319408A1 Remedies for heart failure
06/18/2003EP1319406A1 Novel antibacterial compounds
06/18/2003EP1319405A1 Composition comprising a mixture of bioflavonols
06/18/2003EP1319404A2 Composition for treating and/or prophylaxis of tumors of the breast
06/18/2003EP1319403A1 Remedies for cisplatin-tolerant cancer
06/18/2003EP1319402A1 Ige production inhibitors
06/18/2003EP1319401A1 Compositions for regulating desire for smoking
06/18/2003EP1319397A1 Suppositories sustained in the lower rectum
06/18/2003EP1319186A1 Prognostic indicator
06/18/2003EP1319183A2 Methods and products related to low molecular weight heparin
06/18/2003EP1319069A2 Compositions and methods for the therapy and diagnosis of lung cancer
06/18/2003EP1319014A1 Antisense modulation of flip-c expression
06/18/2003EP1319011A1 Triazolo-epothilones
06/18/2003EP1319009A1 Intermediates in cephalosporin production
06/18/2003EP1319008A2 Water soluble rapamycin esters
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319006A1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
06/18/2003EP1319005A2 Substituted azepino[4,5-b]indoline derivatives
06/18/2003EP1319004A2 Substituted azepino[4,5-b]indole derivatives
06/18/2003EP1319003A1 Xanthine phosphodiesterase v inhibitors
06/18/2003EP1319002A1 Alpha v integrin receptor antagonists
06/18/2003EP1319001A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
06/18/2003EP1319000A1 1-azabicyclo 2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
06/18/2003EP1318999A1 Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
1 ... 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 ... 7860